Prominent pharmaceutical industry ally Anna Eshoo to retire
WASHINGTON — Rep. Anna Eshoo, one of the House of Representatives’ top Democrats on health care issues and a longtime pharmaceutical industry ally, is planning
WASHINGTON — Rep. Anna Eshoo, one of the House of Representatives’ top Democrats on health care issues and a longtime pharmaceutical industry ally, is planning
WASHINGTON — Senate Democrats, led by Sen. Bernie Sanders (I-Vt.) on Tuesday mounted a public pressure campaign to get the executives of Merck, Johnson &
A newly developed artificial intelligence (AI) system that analyzes specialized MRIs of the brain accurately diagnosed children between the ages of 24 and 48 months
As an extremely aggressive form of skin cancer, cutaneous melanoma is still associated with a high mortality rate. Enormous progress has recently been made in
Share this article KOLs have expressed enthusiastic support for gene therapy in the Gaucher disease drug market. Credit: metamorworks/Shutterstock. According to several key opinion leaders
Share this article MSD will acquire Caraway in a deal worth up to $610m, including upfront and milestone-based payments. Image Credit: JHVEPhoto / Shutterstock. MSD
Following the reverse share split, the Company will have 607,381 Ordinary Shares issued and outstanding Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or
Share this article Ensem’s CDK2 inhibitor blocks the activity of cyclin-dependent kinase 2, thereby targeting uncontrolled cell growth. Credit: andresr via Getty Images. BeiGene has
MedSpray’s patented nose-to-brain intranasal technology selected for SPC-15 drug delivery Exclusivity covers multiple indications including anxiety disorders, Alzheimer’s disease, and anorexia Silo Pharma, Inc. (Nasdaq: SILO)
Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics